Search results
Results from the WOW.Com Content Network
These liposomes may be digested while in the macrophage's phagosome, thus releasing its drug. Liposomes can also be decorated with opsonins and ligands to activate endocytosis in other cell types. Regarding pH-sensitive liposomes, there are three mechanisms of drug delivery intracellularly, which occurs via endocytosis. [26]
Cationic liposomes are manufactured similarly to liposomes. There are multiple processes that can be used to form cationic liposomes, such as sonication, extrusion, and vortexing. However, the shear forces associated with these methods are capable of damaging the nucleic acids prior to encapsulation.
Scheme of a liposome formed by phospholipids in an aqueous solution [further explanation needed]. In cell biology, a vesicle is a structure within or outside a cell, consisting of liquid or cytoplasm enclosed by a lipid bilayer.
Liposomes have a lipid outer layer that can be used to bind ligands. Conjugation of the ligand to the surface of a liposome can be achieved through multiple routes. Covalent binding [ 5 ] [ 6 ] is a prominent way due to the anchoring between the long-chain fatty acids and the ligand.
Liposomes are composite structures made of phospholipids and may contain small amounts of other molecules. Though liposomes can vary in size from low micrometer range to tens of micrometers, unilamellar liposomes, as pictured here, are typically in the lower size range with various targeting ligands attached to their surface allowing for their surface-attachment and accumulation in ...
Unilamellar liposomes are used to study biological systems and to mimic cell membranes, and are classified into three groups based on their size: small unilamellar liposomes/vesicles (SUVs) that with a size range of 20–100 nm, large unilamellar liposomes/vesicles (LUVs) with a size range of 100–1000 nm and giant unilamellar liposomes ...
The liposomes were then studied to uncover the properties of biological membranes and a hydration method was discovered to prepare artificial liposomes from 1968 to 1975. [2] Since then, multiple methods of preparing liposomes have been utilized and their characteristics (physical and chemical) have been studied. [2]
Liposomes have the potential to protect the drug from degradation, target sites for action, and reduce toxicity and adverse effects. [7] Lipid nanoparticles can be manufactured by high pressure homogenization, a current method used to produce parenteral emulsions.